ATF4 and SLC7A11 as biomarkers predicting progression and prognosis in lung adenocarcinoma
Background Lung adenocarcinoma (LUAD) is the most prevalent subtype of non-small cell lung cancer, yet reliable biomarkers for stratifying early-stage patients at high risk of progression and poor prognosis remain limited. Methods We enrolled 168 LUAD patients who underwent surgery at The Fourth Hospital of Hebei Medic...